Overall, this produces a net decrease in adipose tissue and a net energy consumption (i.e
ROS, suppression of antioxidant pathways, or a lack of reduced GSH have been identified as instigators or components of many pathologies including inflammatory bowel disease (IBD) 53 , environmental enteropathy 54,55 and cancer 56,57
A Narrative Review
safe in long-term use for approved indications.[38][64] Common Side Effects : Injection site reactions (24-37%), arthralgia, headache.[65][66] Absolute Contraindications : Active malignancy, pregnancy, hypersensitivity.[67][68] Relative Contraindications : Diabetes (monitor glucose), severe renal/hepatic impairment.[69][70] Monitoring Parameters : VAT, lipids, glucose, IGF-1 every 3 months.[71][72] Regulatory Status FDA Classification : Approved as Egrifta for HIV lipodystrophy
J Hematol Oncol 13(1):156 Zhao S, Huang M, Yan L, Zhang H, Shi C, Liu J, Zhao S et al (2022a) Exosomes Derived from Baicalin-Pretreated Mesenchymal Stem Cells Alleviate Hepatocyte Ferroptosis after Acute Liver Injury via the Keap1-NRF2 Pathway
